These early results helped researchers figure out that a once-weekly injection could work and what dose ranges to study next
Accessed October 20, 2024.
In September 2023 the FDA placed BPC-157 in Category 2 of its 503A interim bulk-substances policy, citing immunogenicity and peptide-characterization concerns, effectively excluding it from the 503A compounding bulk-substances list
Research into this peptide has shown some patients experiencing significant weight loss thanks to this peptide
But some people like it, it helps them relax, and it's a real good social lubricant
it reportedly heals ulcers, regenerates nerves, aids muscle and tendon repair, counters neurodegenerative diseases, and protects organs from injuries